Providing a fast lane to preclinical development
The past year has been very productive at the relatively small Contract Research Organisation (CRO) Redoxis. Being specialised in preclinical drug development and efficacy evaluation models, Redoxis offers invaluable support to any pharmaceutical drug developer at the very early stages.
“A lot of CROs tend to focus on the later phases of development, even if they still retain a preclinical app